Hello, welcome toPeanut Shell Foreign Trade Network B2B Free Information Publishing Platform!
18951535724
  • 2 sessions: china drug development

       2026-03-25 NetworkingName1950
    Key Point:▍ author / haruTwo sessions. These representatives are helping chinese medicineTwo meetings. Chinese medicine is of great interestDuring the two national conferences in 2021, the report on the work of the government made it clear that it was important to maintain the balance between chinese and western medicine and to implement major projects for the revitalization and development of chinese medicine。In february 2021, the general off

    ▍ author / haru

    Two sessions. These representatives are helping chinese medicine

    Two meetings. Chinese medicine is of great interest

    During the two national conferences in 2021, the report on the work of the government made it clear that it was important to maintain the balance between chinese and western medicine and to implement major projects for the revitalization and development of chinese medicine。

    In february 2021, the general office of the state council of china issued a number of policy measures to accelerate the development of chinese medicine and medicine characteristics. Through 28 policy measures, policy support and investment in chinese medicine have been increased. Taking advantage of the country's medical advantages and completing the short-term development of chinese medicine has been the subject of two discussions over the past three years and one of the directions of the development of medical and health care in the country。

    It is recalled that since 2020, chinese medicine has played an important role in the prevention and treatment of the epidemic at home. Clinical efficacy observations of confirmed cases of new coronary pneumonia show that chinese medicine is generally more than 90 per cent efficient. The chinese-western medical complex, the chinese-west drug combination programme, has received increasing attention, and the chinese pharmaceutical industry has opened up new historical opportunities。

    What proposals and recommendations have been put forward so far by representatives of the chinese and chinese pharmaceutical industries during the 13th session of the political consultative council and the 13th national people's congress, which were inaugurated in beijing on 4 march and 5 march, respectively

    Chinese medicine. Two meetings

    Representative of the national people's congress, chairman of the board of directors of sunlight biotechnic co. Ltd., lu qingzhou: accelerating the development of chinese medicine

    According to lu qingxing, the current situation in the chinese pharmaceutical industry is not encouraging, with small, scattered and chaotic chinese drug production. There are more than 5,000 home-based pharmacies in the country, with more than 10,000 chinese drug batch numbers, with an annual income of around 800 billion yuan; harmful competition, low-level duplication, and light management of heavy marketing techniques are widespread, wasting social resources and making government regulation more difficult. The introduction of a centralized procurement tender for chinese medicines can be an effective means of promoting the large-scale production of chinese medicines, reducing the cost of chinese medicines and promoting the healthy development of the chinese pharmaceutical industry。

    Professional committee for medical intellectual property research

    He therefore suggested that conditions should be created for the rapid entry of chinese medicines into the mechanism for the procurement of centralized drug shipments, that more chinese drug producers should compete fairly; that the standard system should be improved, that the chinese drug formulation particles should be included in the centralized drug tender system and that the development of chinese drug formulation particles should be promoted。

    Representative of the national people's congress, chairman of the board of directors, jiangsu kangcai limited: improving the evaluation system for technology and innovation in chinese medicine

    Given that the current system of evaluation of chinese medicine and medicine is dominated by western medicine, does not take fully into account the characteristics of chinese medicine, does not allow for the objective, impartial, full and accurate evaluation of chinese medicine, and is unable to effectively stimulate the continuous and innovative development of chinese medicine, he recommended that the system of evaluation of chinese medicine and medicine technology and innovation be improved to promote industrial development。

    First, an independent and autonomous evaluation system based on chinese medicine is being explored and no longer dependent on western medicine evaluation systems. Second, a systematic study of the specific characteristics of chinese medicine establishes a classification evaluation mechanism that is closely linked to the characteristics of the subject of evaluation. The third is the development of an objective, standardized and specialized third-party medical science and technology evaluation body. Fourth is methodological research on scientific and technological evaluation of chinese medicine and the progressive development of evaluation criteria and methodological systems appropriate to the characteristics of chinese medicine。

    Representative of the national people's congress, chairman of the good doctors pharmacy group, gen fung fuen: building a new drug research and development system based on chinese medicine theory

    On how to transmit the development of the pharmaceutical industry, he proposed the establishment of a new system of research and development based on chinese medicine theory and based on clinical values. It is argued that safe and effective are the core values of medicines and cannot be tied to the principle of composition and that clinical values are the criteria for new medicines。

    It was also mentioned that the coverage of chinese medical services by health insurance is still relatively narrow, and that the application of the specialty approach to hospitals in china and the application of the specialty in hospitals is further constrained by the limitation of reimbursement for the use of medical products. He therefore also suggested that health insurance should increase the amount and proportion of reimbursement for chinese pharmaceutical products. In addition, he stressed the importance of developing a pharmaceutical base and establishing a system of drug traceability。

    Wang wei ming, a member of the national political consultative council and a scientist in the technical system of the chinese pharmaceutical industry: increased support for the innovative development of the chinese pharmaceutical industry

    It is recommended that the state integrate the development of the chinese pharmaceutical industry into budgetary management and support the development of agricultural parks, industrial estates and industrial clusters. At the same time, it is recommended that the state integrate the innovative development of the chinese pharmaceutical industry into policy support and provide some policy and financial support for the regularization and management of chinese seedlings, the protection of wild resources, and the construction of seed breeding systems。

    Representative of the national people's congress and chairman of the board of directors of jiji tung corp. Ltd., lee jin-guk: all-round development medicine

    Professional committee for medical intellectual property research

    In his view, the development of medicine should be approached in many ways, and in developing a development model that is consistent with chinese medicine development patterns, he suggested that standards should guide the development of a system of standard evaluation that is consistent with chinese medicine characteristics and stimulates the dynamism and innovation of chinese medicine services. In the area of science and technology, which contribute to the modernization of chinese medicine, li jin-chuk proposes to modernize chinese medicine practice; accelerate the modernization of chinese medicine products; and promote the modernization of knowledge of chinese medicine disciplines。

    Zhang burly, representative of the national people's congress and member of the chinese engineering academy: improving the policy supporting the chinese medicine industry

    The current state of affairs in the chinese and chinese medicine industry is that the top-level design of the country and the general public are very supportive of developing medicine, but many of the accompanying policies are slow to follow. He therefore recommended that policies such as evaluation criteria, access to health care that conformed to chinese medicine characteristics be accelerated to create a sound environment for innovative development。

    In addition, he mentioned that the negative voices of the outside world about chinese medicine were now diminishing, especially after the disease, but still had a bad voice. It is also important to note that there are voices that overstate chinese medicine, and that a good public opinion environment can promote its healthy and high-quality development。

    Fuchun, representative of the national people's congress and vice-rector, henan chinese university of medicine: building and improving the community-based system of medium medicine services

    Sfu-chun recommended that “the effectiveness of chinese medicine services in the community should be continuously enhanced through the development of an internet-based platform for the management of chinese medicine plus infectious diseases or major epidemics, as well as an intelligent chinese medicine community health service”

    Representative of the national people's congress and president of shandong step pharmaceuticals co., inc., zhao chau: playing the role of medical treatment in chinese medicine

    In his view, chinese medicine would play an irreplaceable role in the context of population ageing and the rising incidence of chronic diseases. He suggested that a major effort be made to raise awareness among chinese doctors of the need to “care”. The second is to take advantage of chinese medicine to achieve early treatment of slow diseases. The third is to take advantage of chinese medicine in the acute treatment of slow diseases. Fourth is the application of chinese medicine to improve the rehabilitation of slow patients. Fifth is the further increase in the proportion of the population serving chinese medicine。

    Member of the national political consultative council and professor wu hwang-hyun of the shanghai university of medicine: building a talent system for standardization of chinese medicine

    Prof. Wu hwang-hyun has developed a deep understanding of the post-emergence recommendations of chinese medicine abroad, “to further build on and build on the results of chinese medicine in the field of disease prevention and control, and to produce a real `combat'”. He revealed to journalists that he would submit proposals for further development of the chinese medical epidemic: “further promotion of the development of a standardized chinese medical talent system, strengthening of the building and development of the chinese medical epidemiological disciplines, etc., are of concern to me.”

    Ma guangyu, member of the national political council and vice-president of the political council of guangdong province: protecting chinese medicine patent resources

    Professional committee for medical intellectual property research

    In his proposal for the recommendation on promoting international protection of intellectual property rights in chinese medicines, he suggested that the authorities concerned should make careful decisions about openness and that intellectual property rights should be assessed to protect chinese medicine resources prior to disclosure of prescriptions, formulations and processes, based on the current number of invalid patents, the number of expired patents, the slow process of internationalization and the low percentage of pct applications in the area of chinese medicine (plant medicine). At the same time, companies should be encouraged to dig up intellectual property rights in chinese medicine, increase their support and technical guidance for international patent applications for chinese medicine, and promote the “outside” of chinese medicine in the context of the “one-way road” initiative, international cooperation for the prevention and control of new epidemics and the active expansion of foreign markets。

    Representative of the national people's congress and vice-president of the chongqing city hospital, lee yeonping: innovative research to strengthen the development of chinese medicine in chuan chui

    The representative of yonping li suggested that kawachi should undertake innovative research on the development of chinese medicine in kawazu, through, inter alia, the organization of occasional studies, the exchange of experts and the open laboratory platform, “to break the barriers between the two places and to exchange and learn from one another”. In-depth cooperation between the medical community in the fields of talent, scientific research, teaching, industry, circulation and policy should be strengthened on a continuous basis in order to achieve complementarity of strengths, resources and mutual progress。

    China to the party central committee

    The proposal to promote the international development of the chinese and chinese pharmaceutical industries in our country proposes, first, to create a good environment for external exports by taking steps. The second is to strengthen scientific research and enhance the competitiveness of exports. Thirdly, domestic and foreign capital has been brought together to grow chinese medicine adapted to local conditions. Fourth is the innovative way of exporting and promoting chinese medicine culture。

    Central committee of the china agro-industrial democratic party

    The proposal to actively advance the process of “industrialization, modernization, internationalization” of chinese medicine proposes, first, the establishment of a new national system of national teams for technological innovation and technological innovation in chinese medicine. The second is to further consolidate and improve the integrity of the supply chain of the chinese and chinese pharmaceutical manufacturing and service industries. Thirdly, a major acceleration in the movement of chinese medicine to the world。

    Central committee of the taiwan democratic autonomy alliance

    The proposal for the resolution of selected issues in the practice of chinese medicine passage recommends that the first is the further development of chinese medicine education in various ways. The second is the creation of a brand of “name, name, institution” at all levels of chinese medicine and medical institutions to enhance their overall capacity. The third is to increase the coverage and percentage of reimbursement for chinese medicine and to promote the implementation of chinese medicine. Fourth is the development of institutional mechanisms for the development of chinese and chinese medicine talent at all levels. Fifth is the improvement of mechanisms for the conservation and use of chinese medicine resources and the inclusion of chinese medicine cultivation in the restructuring of the agricultural industry。

    The copyright is owned by id:mic366 and is not authorized to reproduce references

     
    ReportFavorite 0Tip 0Comment 0
    >Related Comments
    No comments yet, be the first to comment
    >SimilarEncyclopedia
    Featured Images
    RecommendedEncyclopedia